Balance Sheet Viveon Health Acquisition Corp.

Equities

Market Closed - OTC Markets Other stock markets 01:35:15 2024-05-03 pm EDT			5-day change	1st Jan Change
10.00 ^USD	-.--%		-.--%	-11.35%

Jun. 06	Viveon Health Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2023	Sector Update: Health Care	MT

7499211ba8963.7LOijnK4GRlb-WWVWxxNN3TpkP9UhtyGdaS0hkRf1BU.2obk3CvdIWtvyCTlKSk9XSCA_6ARzLa-OMuB6wZt5SKj6szBLYtOIAOwMA

Published financial data: VIVEON HEALTH ACQUISITION CORP.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022
Selling General & Admin Expenses, Total	62.48K	3.75M	2.13M
Stock-Based Compensation (IS)	-	157K	-
Other Operating Expenses	-	197K	246K
Other Operating Expenses, Total	62.48K	4.11M	2.37M
Operating Income	-62.48K	-4.11M	-2.37M
Interest Expense, Total	-	-	-3.65M
Interest And Investment Income	511	20.48K	725K
Net Interest Expenses	511	20.48K	-2.92M
Other Non Operating Income (Expenses)	-	6.58M	4.87M
EBT, Excl. Unusual Items	-61.97K	2.49M	-425K
EBT, Incl. Unusual Items	-61.97K	2.49M	-425K
Income Tax Expense	-	-	61.31K
Earnings From Continuing Operations	-61.97K	2.49M	-487K
Net Income to Company	-61.97K	2.49M	-487K
Net Income - (IS)	-61.97K	2.49M	-487K
Net Income to Common Incl Extra Items	-61.97K	2.49M	-487K
Net Income to Common Excl. Extra Items	-61.97K	2.49M	-487K
Per Share Items
Net EPS - Basic	-	0.1	-0.04
Basic EPS - Continuing Operations	-	0.1	-0.04
Basic Weighted Average Shares Outstanding	-	24.15M	12.22M
Net EPS - Diluted	-	0.1	-0.04
Diluted EPS - Continuing Operations	-	0.1	-0.04
Diluted Weighted Average Shares Outstanding	-	24.15M	12.22M
Normalized Basic EPS	-	0.06	-0.02
Normalized Diluted EPS	-	0.06	-0.02
Supplemental Items
EBITA	-62.48K	-4.11M	-2.37M
EBIT	-62.48K	-4.11M	-2.37M
Effective Tax Rate - (Ratio)	-	-	-14.41
Current Domestic Taxes	-	-	101K
Total Current Taxes	-	-	101K
Deferred Domestic Taxes	-	-	-39.26K
Total Deferred Taxes	-	-	-39.26K
Normalized Net Income	-38.73K	1.56M	-266K
Supplemental Operating Expense Items
General and Administrative Expenses	-	2.7M	1.37M
Stock-Based Comp., Other (Total)	-	157K	-
Total Stock-Based Compensation	-	157K	-

Fiscal Period: December	2020	2021	2022
Assets
Cash And Equivalents	3.1M	395K	19.85K
Total Cash And Short Term Investments	3.1M	395K	19.85K
Other Receivables	-	15K	-
Total Receivables	-	15K	-
Prepaid Expenses	661K	3.86K	48.73K
Total Current Assets	3.76M	414K	68.57K
Deferred Tax Assets Long-Term	-	-	39.26K
Other Long-Term Assets, Total	203M	203M	53.82M
Total Assets	207M	204M	53.92M
Liabilities
Accounts Payable, Total	-	47.72K	227K
Accrued Expenses, Total	964K	2.14M	2.6M
Short-term Borrowings	229K	-	4.08M
Other Current Liabilities	365K	-	34M
Total Current Liabilities	1.56M	2.19M	40.91M
Other Non Current Liabilities	200M	214M	29.09M
Total Liabilities	202M	217M	70M
Common Stock, Total	601	503	503
Additional Paid In Capital	5.03M	157K	-
Retained Earnings	-25.82K	-13.14M	-16.08M
Total Common Equity	5M	-12.99M	-16.08M
Total Equity	5M	-12.99M	-16.08M
Total Liabilities And Equity	207M	204M	53.92M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	25.16M	10.06M	6.65M
ECS Total Common Shares Outstanding	25.16M	25.16M	6.88M
Book Value / Share	0.2	-0.52	-2.34
Tangible Book Value	5M	-12.99M	-16.08M
Tangible Book Value Per Share	0.2	-0.52	-2.34
Total Debt	229K	0	4.08M
Net Debt	-2.87M	-395K	4.06M
Account Code - Inventory Valuation	3	3	3
Part Time Employees	2	2	2

Fiscal Period: December	2020	2021	2022
Net Income	-61.97K	2.49M	-487K
Amortization of Deferred Charges, Total - (CF)	-	-	3.65M
Stock-Based Compensation (CF)	-	157K	-
Other Operating Activities, Total	-384	-6.6M	-5.63M
Change In Accounts Payable	2.3M	47.72K	179K
Change In Income Taxes	-	-	101K
Change in Other Net Operating Assets	-696K	1.82M	438K
Cash from Operations	1.54M	-2.08M	-1.75M
Other Investing Activities, Total	-488M	-	150M
Cash from Investing	-488M	-	150M
Short Term Debt Issued, Total	229K	-	4.08M
Total Debt Issued	549K	-	4.08M
Short Term Debt Repaid, Total	-	-229K	-
Total Debt Repaid	-	-229K	-
Issuance of Common Stock	483M	-	-
Repurchase of Common Stock	-	-	-152M
Other Financing Activities, Total	10.11M	-391K	-437K
Cash from Financing	494M	-619K	-149M
Net Change in Cash	7.43M	-2.7M	-375K
Supplemental Items
Levered Free Cash Flow	-	-543K	34.5M
Unlevered Free Cash Flow	-	-543K	33.13M
Change In Net Working Capital	-	-1.87M	-34.62M
Net Debt Issued / Repaid	549K	-229K	4.08M

Fiscal Period: December	2020	2021	2022
Profitability
Return on Assets	-	-1.25	-1.15
Return on Total Capital	-	18.33	11.86
Return On Equity %	-	-17.42	3.35
Return on Common Equity	-	-17.42	3.35
Short Term Liquidity
Current Ratio	2.41	0.19	0
Quick Ratio	1.99	0.19	0
Operating Cash Flow to Current Liabilities	0.99	-0.95	-0.04
Long Term Solvency
Total Debt/Equity	4.58	-	-25.34
Total Debt / Total Capital	4.37	-	-33.94
Total Liabilities / Total Assets	97.58	106.38	129.82
EBIT / Interest Expense	-	-	-0.65
Growth Over Prior Year
EBITA, 1 Yr. Growth %	-	279.77	-42.24
EBIT, 1 Yr. Growth %	-	279.77	-42.24
Earnings From Cont. Operations, 1 Yr. Growth %	-	-146.34	-119.55
Net Income, 1 Yr. Growth %	-	-146.34	-119.55
Normalized Net Income, 1 Yr. Growth %	-	-146.34	-117.09
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-138.62
Total Assets, 1 Yr. Growth %	-	-1.61	-73.53
Tangible Book Value, 1 Yr. Growth %	-	-16.8	23.83
Common Equity, 1 Yr. Growth %	-	-16.8	23.83
Cash From Operations, 1 Yr. Growth %	-	-235.08	-15.8
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-6.46K
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-6.2K
Compound Annual Growth Rate Over Two Years
EBITA, 2 Yr. CAGR %	-	-	48.1
EBIT, 2 Yr. CAGR %	-	-	48.1
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-69.9
Net Income, 2 Yr. CAGR %	-	-	-69.9
Normalized Net Income, 2 Yr. CAGR %	-	-	-71.86
Total Assets, 2 Yr. CAGR %	-	-	-48.96
Tangible Book Value, 2 Yr. CAGR %	-	-	1.5
Common Equity, 2 Yr. CAGR %	-	-	1.5
Cash From Operations, 2 Yr. CAGR %	-	-	6.65